Literature DB >> 11511832

Confocal scanning laser microscopy of benign and malignant melanocytic skin lesions in vivo.

R G Langley1, M Rajadhyaksha, P J Dwyer, A J Sober, T J Flotte, R R Anderson.   

Abstract

BACKGROUND: The ability of physicians for early diagnosis of cutaneous melanomas is less than perfect, prompting research into noninvasive methods for diagnosis.
OBJECTIVE: Our purpose was to evaluate confocal scanning laser microscopy (CSLM) for noninvasive imaging of benign and malignant melanocytic lesions in vivo.
METHODS: Forty pigmented skin lesions (including adjacent normal skin as control) in vivo were imaged with near-infrared CSLM. The confocal images were correlated to histopathology.
RESULTS: Nuclear, cellular, and architectural detail in the epidermis and superficial dermis is imaged with high resolution and contrast. Melanin causes the cytoplasm of pigmented cells to appear bright. Melanocytic nevi had cohesive nests of uniformly circular cells and increased microvascular blood flow. Melanomas had a polymorphous cytologic structure, containing atypical, pleomorphic cells in disarray and irregular dendritic cells.
CONCLUSION: CSLM is capable of identifying distinct patterns and cytologic features of benign and malignant pigmented skin lesions in vivo. CSLM may be useful to noninvasively discriminate benign and malignant lesions in vivo.

Entities:  

Mesh:

Year:  2001        PMID: 11511832     DOI: 10.1067/mjd.2001.117395

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  26 in total

1.  [Confocal laser scanning microscopy].

Authors:  S Astner; M Ulrich
Journal:  Hautarzt       Date:  2010-05       Impact factor: 0.751

2.  Automated detection of malignant features in confocal microscopy on superficial spreading melanoma versus nevi.

Authors:  Dan Gareau; Ricky Hennessy; Eric Wan; Giovanni Pellacani; Steven L Jacques
Journal:  J Biomed Opt       Date:  2010 Nov-Dec       Impact factor: 3.170

3.  Distinguishing between benign and malignant melanocytic nevi by in vivo multiphoton microscopy.

Authors:  Mihaela Balu; Kristen M Kelly; Christopher B Zachary; Ronald M Harris; Tatiana B Krasieva; Karsten König; Anthony J Durkin; Bruce J Tromberg
Journal:  Cancer Res       Date:  2014-03-31       Impact factor: 12.701

4.  Detection and diagnosis of oral neoplasia with an optical coherence microscope.

Authors:  A L Clark; A Gillenwater; R Alizadeh-Naderi; A K El-Naggar; R Richards-Kortum
Journal:  J Biomed Opt       Date:  2004 Nov-Dec       Impact factor: 3.170

5.  Evaluation of human knee meniscus biopsies with near-infrared, reflectance confocal microscopy. A pilot study.

Authors:  Vanessa Campo-Ruiz; Dinesh Patel; R Rox Anderson; Emilio Delgado-Baeza; Salvador González
Journal:  Int J Exp Pathol       Date:  2005-10       Impact factor: 1.925

6.  Nanostructured Lipid Carrier for Topical Application of N-Acetyl Glucosamine.

Authors:  Lavin Aliasgharlou; Saeed Ghanbarzadeh; Hamideh Azimi; Mohammad Hossein Zarrintan; Hamed Hamishehkar
Journal:  Adv Pharm Bull       Date:  2016-12-22

7.  Confocal microscopy and molecular-specific optical contrast agents for the detection of oral neoplasia.

Authors:  Alicia L Carlson; Ann M Gillenwater; Michelle D Williams; Adel K El-Naggar; R R Richards-Kortum
Journal:  Technol Cancer Res Treat       Date:  2007-10

Review 8.  [Confocal laser scanning microscopy].

Authors:  M Ulrich
Journal:  Hautarzt       Date:  2015-07       Impact factor: 0.751

9.  Using LongSAGE to Detect Biomarkers of Cervical Cancer Potentially Amenable to Optical Contrast Agent Labelling.

Authors:  Julie M Kneller; Thomas Ehlen; Jasenka P Matisic; Dianne Miller; Dirk Van Niekerk; Wan L Lam; Marco Marra; Rebecca Richards-Kortum; Michelle Follen; Calum Macaulay; Steven J M Jones
Journal:  Biomark Insights       Date:  2007-12-11

Review 10.  Current and emerging technologies in melanoma diagnosis: the state of the art.

Authors:  Estee L Psaty; Allan C Halpern
Journal:  Clin Dermatol       Date:  2009 Jan-Feb       Impact factor: 3.541

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.